A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia

Health Technology Assessment

Volumn 7, Issue 8, 2003, Pages

  Kennedy, A D M ^a   Sculpher, M J ^b   Coulter, A ^c   Dwyer, N ^d   Rees, M ^e   Horsley, S ^f   Cowley, D ^g   Kidson, C ^h   Kirwin, C ⁱ   Naish, C ^e   Bidgood, K ^h   Cullimore, J ^f   Kerr Wilson, R ⁱ   Abrams, K R ^j   Stirrat, G ^g  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c PICKER INSTITUTE EUROPE   (United Kingdom)

^d WESTON GENERAL HOSPITAL   (United Kingdom)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f PRINCESS MARGARET HOSPITAL   (United Kingdom)

^g ST MICHAEL'S HOSPITAL   (United Kingdom)

^h TAUNTON AND SOMERSET HOSPITAL   (United Kingdom)

ⁱ St Paul's Medical Centre   (United Kingdom)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DANAZOL; HORMONE; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEFENAMIC ACID; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; PREMPAK; TRANEXAMIC ACID;

CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONSULTATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DOCTOR PATIENT RELATION; DRUG COST; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH STATUS; HEALTH SURVEY; HOSPITAL; HUMAN; HYSTERECTOMY; INTERVIEW; INTRAUTERINE CONTRACEPTIVE DEVICE; LONG TERM CARE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL SPECIALIST; MENORRHAGIA; MULTICENTER STUDY; NURSE; OUTCOMES RESEARCH; OUTPATIENT CARE; PARALLEL DESIGN; PATIENT COMPLIANCE; PATIENT INFORMATION; PATIENT REFERRAL; PATIENT SATISFACTION; POLYPECTOMY; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RADICAL HYSTERECTOMY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIVITY ANALYSIS; UNITED KINGDOM; CONFIDENCE INTERVAL; ECONOMICS; MEDICAL TECHNOLOGY; MULTICENTER STUDY (TOPIC); PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BIOMEDICAL TECHNOLOGY; CONFIDENCE INTERVALS; ENGLAND; FEMALE; HUMANS; MENORRHAGIA; MULTICENTER STUDIES AS TOPIC; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85045798198     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta7080     Document Type: Review

References (63)

1. Corrado M. Women's Health in 1990. London: MORI; 1990.
2. Royal College of General Practitioners. Office of Population Censuses and Surveys. Morbidity Statistics from General Practice 1981-2. London: HMSO; 1986.
3. Coulter A, Peto V, Doll H. Patients' preferences and general practitioners' decisions in the treatment of menstrual disorders. Fam Pract 1994;11:67-74.
4. Sculpher M. A cost-utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. Int J Technol Assess Health Care 1998;14:302-19.
5. Effective Health Care. The Management of Menorrhagia. Leeds: University of Leeds; 1995. Effective Health Care Bulletin No. 9.
6. Vessey M, Villard-Mackintosh L, McPherson K, Coulter A, Yeates D. The epidemiology of hysterectomy: Findings in a large cohort study. Br J Obstet Gynaecol 1992;99:402-7.
7. Grant JM, Hussein IY. An audit of abdominal hysterectomy over a decade in a district hospital. Br J Obstet Gynaecol 1984;91:73-7.
8. Coulter A, Bradlow J, Agass M, Martin-Bates C, Tulloch A. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: An audit of general practice records. Br J Obstet Gynaecol 1991;98:789-96.
9. Coulter A, Kelland J, Peto V, Rees M. Treating menorrhagia in primary care. Int J Technol Assess Health Care 1995;11:456-71.
10. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: Randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579-82.
11. Hirsch NA. Technologies for the Treatment of Menorrhagia and Uterine Myomas. Canberra: Australian Government Publishing Service; 1993. Australian Institute of Health and Welfare Health Care Technology Series number 10.
12. Sculpher MJ, Dwyer N, Browning J, Horsley S, Cullimore J. A survey of women's preferences regarding alternative surgical treatments for menorrhagia. Health Expect 1998;1:96-105.
13. Kassirer JP. Incorporating patient's preferences into medical decisions. N Engl J Med 1994;330;1895-6.
14. Prentice A. Medical management of menorrhagia. BMJ 1999;319:1343-5.
15. Coulter A. Paternalism or partnership? Patients have grown up - And there's no going back. BMJ 1999;319:719-20.
16. Domenighetti G, Luraschi P, Casabianca A. Effect of information campaign by the mass media on hysterectomy rates. Lancet 1988;ii:1470-3.
17. Mazur DJ, Hickam DH. The effect of physicians' explanations on patients' treatment preferences: Five-year survival data. Med Decis Making 1994;14:255-8.
18. Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care 1988;26:657-75.
19. Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ, et al. Attitudes to chemotherapy: Comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990;300:1458-60.
20. Wilson RG, Hart A, Dawes P. Mastectomy or conservation: The patients' choice. BMJ 1988;297:1167-9.
21. Greenfield S, Kaplan S, Ware JE. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med 1985;102:520-8.
22. Brody DS, Miller SM, Lerman CE, Smith DG. Patient perception of involvement in medical care: Relationship to illness attitudes and outcomes. J Gen Intern Med 1989;4:506-11.
23. Finch H. Shared Decision-Making Programmes for Hormone Replacement Therapy and Treatment of Benign Conditions of the Uterus. London: Social & Community Planning Research; 1993.
24. Gath D, Osborn M, Bungay G, Iles S, Day A, Bond A, et al. Psychiatric disorder and gynaecological symptoms in middle aged women: A community survey. BMJ 1987;294:213-18.
25. Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 1995;33:771-82.
26. Kempson E. Informing Health Consumers. A Review of Consumer Health Information Needs and Services. London: College of Health; 1987.
27. Buckland S. Unmet needs for health information: A literature review. Health Libr Rev 1994;11:82-95.
28. Pocock SJ. Clinical Trials: A Practical Approach. Chichester: Wiley; 1983.
29. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: New outcome measure for primary care. BMJ 1992;305:160-4.
30. Brooks R. EuroQol: The current state of play. Health Policy 1996;37:53-72.
31. Ruta DA, Garratt AM, Chadha YC, Flett GM, Hall MH, Russell IT. Assessment of patients with menorrhagia: How valid is a structured clinical history as a measure of health status? Qual Life Res 1995;4:33-40.
32. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301-6.
33. O'Connor AM, Rostom A, Fiset V, Tetroe J, Entwistle V, Llewellyn-Thomas H, et al. Decision aids for patients facing health treatment or screening decisions: Systematic review. BMJ 1999;319:731-4.
34. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). Soc Sci Med 1997;44:681-92.
35. Brown H, Prescott R. Applied Mixed Models in Medicine. Chichester: Wiley; 1999.
36. Jenkinson C, Layte R, Wright L, Coulter A. The UK SF-36: An Analysis and Interpretation Manual: A Guide to Health Status Measurement with Particular Reference to the Short Form 36 Health Survey. Oxford: Health Services Research Unit; 1996.
37. Department of Health. The New NHS 1999 Reference Costs. Wetherby: DoH, 1999.
38. Sculpher M, Thompson E, Brown J, Garry R. A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents. Br J Obstet Gynaecol 2000;107:340-6.
39. Netten A, Dennett J. Unit Costs of Health and Social Care. Canterbury: Personal Social Sciences Research Unit (PSSRU), University of Kent, 1999.
40. British National Formulary. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain, 1999. Number 38.
41. Sculpher MJ, Bryan S, Dwyer N, Hutton J, Stirrat GM. An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol 1993;100:244-52.
42. NHS Executive. Nurses' and Midwives' Pay for 1999/00. Leeds: NHS Executive (advanced letter); 1999.
43. National Statistics. Health Statistics (Quarterly). London: HMSO; 2001.
44. Kind P. The EuroQoL instrument: An index of health-related quality of life. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996.
45. Kind P, Hardman G, Macran S. UK Population Norms for EQ-5D. York: Centre for Health Economics, University of York, 1999. Centre for Health Economics Discussion Paper 172
46. Matthews JNS, Altman D, Campbell MJ. Analysis of serial measurements in medical research. BMJ 1990;300:230-5.
47. Efron B, Tibshirani R. An Introduction to the Boostrap. New York: Chapman and Hall; 1993.
48. Rubin DB: Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987.
49. Van Hout BA, Al MJ, Gordon GS, Rutten FFH. Costs, effects and c/e-ratios alongside a clinical trial. Health Econ 1994;3:309-19.
50. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: The role of cost-effectiveness acceptability curves. Health Econ 2001;10:779-87.
51. Briggs AH. A bayesian approach to stochastic cost-effectiveness analysis. Health Econ 1999;8:257-62.
52. Office for National Statistics. Labour Force Survey. London: The Stationary Office; 2000.
53. Review Body on Doctors and Dentists' Remuneration. Report 2000. London: HMSO; 2000.
54. Royal College of Obstetricians and Gynaecologists. A Blue Print for the Future (A Working Party Report on the Future Structure of the Medical Workforce and Service Delivery in Obstetrics and Gynaecology). London: RCOG Press; 2000.
55. Molenaar S, Sprangers MAG, Postma-Schuit FCE, Rutgers EJT, Noorlander J, Hendriks J, et al. Feasibility and effects of decision aids. Med Decis Making 2000;20:112-27.
56. O'Connor AM, Stacey D, Rovner D, Holmes-Rovner M, Tetroe J, Llewellyn-Thomas H, et al. Decision aids for people facing health treatment or screening decisions (Cochrane Review). The Cochrane Library. Issue 3. Oxford: Update Software; 2001.
57. Barry MJ, Cherkin DC, Chang YFowler FJ, Skates S. A randomized trial of a multimedia shared decision-making program for men facing a treatment decision for benign prostatic hyperplasia. Dis Manag Clin Outcomes 1997;1:5-14.
58. Deyo RA, Cherkin DC, Weinstein J, Howe J, Ciol M, Mulley AG Jr. Involving patients in clinical decisions: Impact of an interactive video program on use of back surgery. Med Care 2000;38:959-69.
59. Holmes-Rovner M, Kroll J, Rovner DR, Schmitt N, Rothert M, Padonu G, et al. Patient decision support intervention: Increased consistency with decision analytic models. Med Care 1999;37:270-84.
60. Rothert ML, Holmes-Rovner M, Rovner D, Kroll J, Breer L, Talarczyk G, et al. An educational intervention as decision support for menopausal women. Res Nurs Health 1997;20:377-87.
61. Bernstein SJ, Skarupski KA, Grayson CE, Starling MR, Bates ER, Eagle KA. A randomized controlled trial of information-giving to patients referred for coronary angiography: Effects on outcoms of care. Health Expect 1998;1:50-61.
62. Morgan MW, Deber RB, Llewellyn-Thomas HA, Gladstone P, Cusimano RJ, O'Rourke K, et al. Randomized controlled trial of an interactive videodisc decision aid for patients with ischaemic heart disease. J Gen Intern Med 2000;15:685-93.
63. Street RL, Voigt B, Geyer C, Manning T, Swanson GP. Increasing patient involvement in choosing treatment for early breast cancer. Cancer 1995;76:2275-85.